Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medivive vs Rivas Medical Weight Loss

Medivive
Graded #335

Higher grade

vs+4.100000000000001
Rivas Medical Weight Loss
Graded #437

Lower grade

The verdict

Medivive takes it — 59.7/100 to 55.6/100.

Medivive grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medivive is a US telehealth service offering compounded semaglutide and tirzepatide for weight loss, filled through a licensed pharmacy, with providers licensed in all 50 states and no insurance required.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedivive +26
71
45
Dose & formulationEven
40
40
Clinical oversightRivas Medical Weight Loss +18
63
81
Labs & monitoringMedivive +11
64
53
FulfillmentRivas Medical Weight Loss +4
61
65
Contract termsEven
55
55
Medivive · left barRivas Medical Weight Loss · right bar

The numbers

MetricMediviveRivas Medical Weight Loss
WeighScore59.7/10055.6/100
GradeCC
Scorecard rank#335#437
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published3 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Medivive

Graded #335 · C

Strengths

  • Compounded semaglutide and tirzepatide with providers licensed in all 50 states
  • No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
  • Medication filled through a licensed pharmacy

Where it loses points

  • Monthly pricing not published; disclosed only after an AI intake
  • No legal entity or named pharmacy disclosed
  • Service states are not individually listed

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard